卡博桑提尼布皮肤毒性综合性审查
Cristina Violeta Tutunaru1,2, Dragos Ovidiu Alexandru3, Sanda Amelia Dracea4,5
1Department of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Life (Basel, Switzerland)
|January 25, 2025
概括
这篇评论详细介绍了癌症治疗药物卡博赞提尼布 (Cabozantinib) 的皮肤毒性. 它概述了常见的副作用和管理策略,以改善患者的生活质量.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性癌症疗法需要有效管理不良影响,以保持治疗疗效和患者的生活质量.
- 卡博桑提尼布是一种多酶抑制剂 (MKI),已批准用于晚期癌,肝细胞癌和髓性甲状腺癌.
- 与皮肤相关的毒性是与卡博赞提尼布等多酶抑制剂相关的常见不良事件.
研究的目的:
- 为提供卡博赞提尼布皮肤学副作用的全面概述.
- 为了识别和描述与卡博赞提尼布治疗相关的常见皮肤毒性.
- 根据这些不良影响的严重程度,建议针对这些不良影响采取预防和管理战略.
主要方法:
- 对卡博赞提尼布及其相关皮肤毒性研究和临床数据的文献综述.
- 在临床试验和实际使用中报告的常见皮肤相关不良事件的识别.
- 对管理卡博赞提尼布诱导的皮肤毒性的当前建议的综合.
主要成果:
- 常见的皮肤毒性包括手掌 - 脚掌红色消化症,口腔炎,头发变化,色,阴囊红斑和下裂纹出血.
- 这些皮肤学副作用的严重程度可能会有所不同,影响患者的坚持和生活质量.
- 基于证据的预防措施和管理准则对于优化患者护理至关重要.
结论:
- 有效管理卡博赞提尼布诱导的皮肤毒性对于维持治疗连续性和改善患者的治疗结果至关重要.
- 了解皮肤学副作用的范围,可以进行主动干预和支持性护理.
- 本综述为管理卡博赞提尼布治疗患者的临床医生提供了宝贵的资源.
更多相关视频
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
14.2K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K